The NMDA receptor mediates cortical induction of fos and fos-related antigens following cortical injury.
Cortical cavity lesions and lateral ventricular injections of quinolinic acid, a NMDA receptor agonist, induce Fos and Fos-related antigens (FRAs) throughout ipsilateral adult rat brain cortex in similar patterns. c-fos mRNA, assessed using in situ hybridization, was induced by 1 h and disappeared between 3 and 8 h following cortical lesions. Fos proteins, detected using a specific monoclonal antibody, were induced by 1 h and disappeared by 4 h after cortical lesions. FRA proteins, detected using polyclonal antibodies, were induced between 1 and 4 h and persisted for at least 72 h following focal cortical injury. Intraventricular injections of CPP, a competitive NMDA receptor antagonist, completely blocked the induction of these nuclear proteins in cortex ipsilateral to the focal cortical lesions--except around the injury site itself. Intraventricular injections of quisqualate, a non-NMDA glutamate analogue, induced Fos in hippocampus but not in cortex. These data show that NMDA receptors mediate the induction of Fos and FRAs following cortical injury. It is proposed that local cortical injury releases excitatory amino acids that act at NMDA receptors to initiate spreading depression and that the resultant depolarization induces Fos in neurons throughout the cortex. Since Fos and FRAs are proteins that regulate the expression of target genes, they could mediate long-term biochemical adaptations in neurons following cortical injury.
Department of Neurology, University of California, San Francisco.
J W
JW
Sharp
S M
SM
Sagar
K
K
Hisanaga
P
P
Jasper
F R
FR
Sharp
D000818:Animals; D000941:Antigens / Q000276:immunology*; D002540:Cerebral Cortex / Q000276:immunology* / Q000293:injuries; D005260:Female; D007150:Immunohistochemistry / Q000379:methods; D008297:Male; D009498:Neurotoxins / Q000494:pharmacology; D009693:Nucleic Acid Hybridization; D010879:Piperazines / Q000494:pharmacology; D011518:Proto-Oncogene Proteins / Q000276:immunology*; D016760:Proto-Oncogene Proteins c-fos; D017378:Quinolinic Acid; D011805:Quinolinic Acids / Q000494:pharmacology; D012333:RNA, Messenger; D051381:Rats; D011919:Rats, Inbred Strains; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000502:physiology*; D013194:Staining and Labeling
D000941:Antigens; D009498:Neurotoxins; D010879:Piperazines; D011518:Proto-Oncogene Proteins; D016760:Proto-Oncogene Proteins c-fos; D011805:Quinolinic Acids; D012333:RNA, Messenger; D016194:Receptors, N-Methyl-D-Aspartate; C050592:3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid; D017378:Quinolinic Acid